Michel Arock

16.9k total citations · 1 hit paper
196 papers, 7.8k citations indexed

About

Michel Arock is a scholar working on Immunology, Molecular Biology and Rheumatology. According to data from OpenAlex, Michel Arock has authored 196 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 145 papers in Immunology, 46 papers in Molecular Biology and 42 papers in Rheumatology. Recurrent topics in Michel Arock's work include Mast cells and histamine (120 papers), Food Allergy and Anaphylaxis Research (30 papers) and Asthma and respiratory diseases (28 papers). Michel Arock is often cited by papers focused on Mast cells and histamine (120 papers), Food Allergy and Anaphylaxis Research (30 papers) and Asthma and respiratory diseases (28 papers). Michel Arock collaborates with scholars based in France, Austria and United States. Michel Arock's co-authors include Peter Valent, Wolfgang R. Sperr, Frédéric Féger, Cem Akin, Patrice Debré, Marc Daëron, Karl Sotlar, Odile Malbec, Hans‐Peter Horny and M. Djavad Mossalayi and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Michel Arock

190 papers receiving 7.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes

2012 457 citations Peter Valent, Hans‐Peter Horny et al. Journal of Allergy and Clinical Immunology profile →

Peers

Countries citing papers authored by Michel Arock

Since Specialization

Citations

This map shows the geographic impact of Michel Arock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Arock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Arock more than expected).

Fields of papers citing papers by Michel Arock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Arock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Arock. The network helps show where Michel Arock may publish in the future.

Co-authorship network of co-authors of Michel Arock

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Arock. A scholar is included among the top collaborators of Michel Arock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Arock. Michel Arock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Distinct Tryptase Gene Copy Number Variations Correlate With Tryptase Levels in a Population‐Based Cohort 2025 ·Allergy ·Yannick Chantran, (unknown), Célina Roda, Stéphane Barète, Pierre Hirsch, (unknown), Laura Polivka, Julien Rossignol, Michel Arock, Fanny Rancière, Isabelle Momas	0
2	Impact of Molecular Evaluations in the Biology, Diagnosis, and Prognostication of Patients With Mastocytosis 2025 ·The Journal of Allergy and Clinical Immunology In Practice ·Gregor Hoermann, Alberto Orfao, Jonathan J. Lyons, Yannick Chantran, Sigurd Broesby‐Olsen, Vito Sabato, Michel Arock	0
3	Coronavirus Receptor Expression Profiles in Human Mast Cells, Basophils, and Eosinophils 2024 ·Cells ·(unknown), Irina Sadovnik, (unknown), Barbara Peter, Gabriele Stefanzl, Clemens Gstoettner, Péter Jaksch, Konrad Höetzenecker, Clemens Aigner, Christine Radtke, Michel Arock, Wolfgang R. Sperr, Peter Valent	5
4	Antibody-Based and Cell Therapies for Advanced Mastocytosis: Established and Novel Concepts 2023 ·International Journal of Molecular Sciences ·Peter Valent, Cem Akin, Michel Arock, Karoline V. Gleixner, Hildegard Greinix, Olivier Hermine, Hans‐Peter Horny, (unknown), Alberto Órfão, Werner Rabitsch, Andreas Reiter, Axel Schulenburg, Karl Sotlar, Wolfgang R. Sperr, Celalettin Üstün	1
5	SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted 2023 ·Biomarker Research ·Manuela Mancini, (unknown), (unknown), Cristina Papayannidis, Michela Rondoni, Chiara Sartor, Samantha Bruno, Livio Pagano, Marianna Criscuolo, Roberta Zanotti, Massimiliano Bonifacio, Patrizia Tosi, Michel Arock, Peter Valent, Michèle Cavo, Simona Soverini	4
6	Drug-induced mast cell eradication: A novel approach to treat mast cell activation disorders? 2022 ·Journal of Allergy and Clinical Immunology ·Peter Valent, Cem Akin, Karin Hartmann, Andreas Reiter, Jason Gotlib, Karl Sotlar, Wolfgang R. Sperr, (unknown), (unknown), Massimo Triggiani, Hans‐Peter Horny, Michel Arock, Stephen J. Galli, Dean D. Metcalfe	17
7	Monocyte distribution width (MDW) performance as an early sepsis indicator in the emergency department: comparison with CRP and procalcitonin in a multicenter international European prospective study 2021 ·Critical Care ·Pierre Hausfater, (unknown), Cristian Morales‐Indiano, (unknown), (unknown), J. Pernet, (unknown), (unknown), Diana Careaga, Michel Arock, Liliana Tejidor, (unknown)	68
8	Immunomodulatory role of Interleukin-33 in large vessel vasculitis 2020 ·Scientific Reports ·A.C. Desbois, P. Cacoub, Aurélie S. Leroyer, Edwige Tellier, Marlène Garrido, (unknown), Cloé Comarmond, Stéphane Barète, Michel Arock, Patrick Bruneval, Jean-Marie Launay, Pierre Fouret, Ulrich Blank, Michèlle Rosenzwajg, David Klatzmann, Mohamed Jarraya, Philippe Cluzel, Fabien Koskas, Gilles Kaplanski, David Saadoun	13
9	Acute mast cell leukemia: A rare but highly aggressive hematopoietic neoplasm 2018 ·Diagnostic Cytopathology ·Myrto Costopoulos, Madalina Uzunov, Dominique Bories, Frédéric Charlotte, Karim Maloum, Michel Arock	5
10	Comparative oncology: The paradigmatic example of canine and human mast cell neoplasms 2018 ·Veterinary and Comparative Oncology ·Michael Willmann, Emir Hadzijusufovic, Olivier Hermine, Mauro Dacasto, Laura Marconato, Karin Bauer, Barbara Peter, (unknown), Gregor Eisenwort, Erika Jensen‐Jarolim, Mathias Müller, Michel Arock, David M. Vail, Peter Valent	17
11	Current treatment options in patients with mastocytosis: status in 2015 and future perspectives 2015 ·European Journal Of Haematology ·Michel Arock, Cem Akin, Olivier Hermine, Peter Valent	43
12	Expression of programmed cell death ligand-1 in mastocytosis correlates with disease severity 2015 ·Journal of Allergy and Clinical Immunology ·Anja Rabenhorst, (unknown), Juliana Schwaab, Manuela Gehring, Anja Förster, Michel Arock, Andreas Reiter, Ulrike Raap, Karin Hartmann	14
13	Molecular Defects in Mastocytosis 2014 ·Immunology and Allergy Clinics of North America ·(unknown), (unknown), Sylvie Jeanningros, Fabienne Brenet, Erinn Soucié, Olivier Hermine, Gandhi Damaj, Patrice Dubreuil, Michel Arock	57
14	Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation 2005 ·The Journal of Experimental Medicine ·Jacques Zappulla, Patrice Dubreuil, Sabine Desbois, Sébastien Letard, Nadine Benhamouda, Marc Daëron, Georges Delsol, Michel Arock, Roland Liblau	68
15	Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms 2003 ·Oncogene ·Yaël Zermati, Paulo De Sepulveda, Frédéric Féger, Sébastien Letard, Joëlle Kersual, Nathalie Castéran, Guy Gorochov, Michel Dy, (unknown), Karim Dorgham, Christophe Parizot, (unknown), Michel Vidaud, Olivier Lortholary, Michel Arock, Olivier Hermine, Patrice Dubreuil	150
16	The role of mast cells in host defense and their subversion by bacterial pathogens 2002 ·Trends in Immunology ·Frédéric Féger, (unknown), Zhimin Gao, Soman N. Abraham, Michel Arock	115
17	Thrombopoietin Induces Histidine Decarboxylase Gene Expression in c-mpl Transfected UT7 Cells 2001 ·Biochemical and Biophysical Research Communications ·Maria Pacilio, Najet Debili, Anne Arnould, François Machavoine, Malvyne Rolli‐Derkinderen, (unknown), Michel Arock, Dominique Dumènil, Michel Dy, Elke Schneider	9
18	Anti-proliferative effects of CD23 ligation on normal human keratinocytes: Involvement of TNF-α and nitric oxide 1994 ·Journal of Investigative Dermatology ·Michel Arock, (unknown), Liliane Le Goff, C. Françès, O. Chosidow, Patrice Debré, M. Djavad Mossalayi	1
19	Retinoids exert anti-inflammatory effects on human keratinocytes through inhibition of NO and TNF-α secretion 1994 ·Journal of Investigative Dermatology ·Pierre‐André Bécherel, M. Djavad Mossalayi, Liliane Le Goff, Patrice Debré, C. Françès, O. Chosidow, Michel Arock	7
20	Involvement of FcϵRII/CD23 and L-Arginine Dependent Pathway in IgE-Mediated Activation of Human Eosinophils 1994 ·Biochemical and Biophysical Research Communications ·Michel Arock, (unknown), Pierre‐André Bécherel, Bernard Dugas, Patrice Debré, M. Djavad Mossalayi	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact